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Replicative Senescence: Minireview
An Old Lives' Tale?
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The observation that cell division is inherently limited
contradicted an earlier belief, championed by Carrel,Normal animal cells, with few exceptions, do not divide
that vertebrate cells can proliferate indefinitely once re-indefinitely. This property, termed the finite replicative
moved from the organism. Carrel's belief stemmed inlife span of cells, leads to an eventual arrest of cell
part from his apparent (but since irreproducible) abilitydivision by a process termed cellular or replicative se-
continually to subculture chick cells. This study andnescence.
others (see Hayflick, 1965) spawned the idea that cellsAlthough predicted and observed earlier, replicative
may be intrinsically ªimmortal.º Implicit in some of thesesenescence was first formally described over 30 years
studies was the idea that understanding cell immortalityago when Hayflick and his colleagues reported that hu-
might uncover the basis for organismic mortality (Carrel,man fibroblasts gradually and inevitably lost their ability
1912). With this idea as a backdrop, then, Hayflick as-to proliferate upon continual subculture (Hayflick, 1965).
serted that ªnormal human diploid cell strains in vitroSince then, many cell types from many animal species
are in fact `mortal'º and suggested that replicative lifehave been shown to have a finite replicative life span
span in culture reflects processes that occur during(see Stanulis-Praeger, 1987). Most of these studies have
the chronological life span, or aging, of the organismused cells in culture. However, a limited number of in
(Hayflick, 1965).vivo experiments, as well as the evidence discussed
In retrospect, there was little basis for equating cellhere and elsewhere (Stanulis-Praeger, 1987; Campisi et
replicative life span with organismic life span. Certainly,al., 1996), strongly suggest that cellular senescence is
replicatively immortal cells can die just as readily asnot an artifact of culture.
replicatively mortal cells. Moreover, mammals are repli-
catively immortal (through the germline), even though
Is Replicative Senescence Physiologically individuals age and die. Why, then, was the parallel
Important? between the replicative life span of cells and organismic
In higher organisms, particularly mammals, two views life span, or aging, accepted? In fact, it was not. There
suggest that replicative senescence may have important were 30 years ago, and remain today, many skeptics.
physiologic consequences. Nonetheless, Hayflick and other biologists, perhaps in-
One view holds that cellular senescence is a tumor tuitively, pursued the idea that cellular senescence and
suppressive mechanism. There is substantial molecular, aging are related. As a result, the idea has garnered
cellular, and in vivo evidence to support this idea (Cam- increasing experimental support and increasing interest
pisi et al., 1996). This evidence will not be reviewed here, among biologists.
but is briefly summarized. First, senescence prevents
cells from acquiring the multiple mutations that are
needed for malignant transformation. Indeed, many, if Do All Normal Cells Senesce?
When examined carefully, cells that can divideÐwith anot most, malignant tumors contain cells that have an
extended or indefinite division potential. Thus, tumori- few notable exceptionsÐundergo replicative senes-
cence. However, whether cell senescence is a limitedgenesis selects for cells that can wholly or partly bypass
senescence. Second, certain oncogenesÐboth cellular or universal phenomenon has not been adequately ex-
plored and, for some cells, may not be easy to de-and viralÐact at least in part by extending replicative
life span. Thus, oncogenic mutations and the strategies termine.
Cells from some speciesÐfor example, many ro-of oncogenic viruses may and do entail mechanisms to
overcome senescence. Third, among the genes needed dentsÐspontaneously escape senescence (immortal-
ize) at a measurable frequency (1 in 104±106 cells). Be-to establish and maintain senescence are the p53 and
retinoblastoma susceptibility genes. These are well-rec- cause immortal cells rapidly overgrow senescing
cultures, it can be difficult to assess the replicative lifeognized tumor suppressors that, together, are the most
commonly lost functions in human cancer. A related span of some cells in massculture. Nonetheless, several
cell types from a wide (but hardly exhaustive) variety ofidea suggests that tumor suppression is the adaptive
value of senescence, but senescence may have evolved species have been shown to have a finite replicative life
span (Rohme, 1981; see Stanulis-Praeger, 1987). Repli-to fine-tune tissue modeling during development (Mar-
tin, 1993). Of course, there is also intuitive and teleologic cative senescence is especially stringent in human cells,
which almost never spontaneously immortalize (McCor-appeal to the idea that a growth-limiting process may
suppress tumorigenesis. mick and Maher, 1988).
Even some single-celled organisms, such as Sacchar-A second view regarding the physiologic significance
of cell senescence holds that it reflects processes that omyces cerevisiae, clearly senesce when individual cells
are monitored (Jazwinski, 1993). This suggests that aoccur during organismic aging and may constitute an
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finite replicative life span may be a very primitive pheno- independent studies show a significant inverse relation-
ship between donor age and replicative capacity of cul-type. There is, however, a major difference in this regard
tured cells (Martin et al., 1970; see Stanulis-Praeger,between higher eukaryotes and S. cerevisiae. In higher
1987; Cristofalo and Pignolo, 1993; Campisi et al., 1996).organisms, daughter cells inherit the replicative ªageº
For example, human fetal fibroblasts typically senesceof their mother, minus one division. Thus, mammalian
after 60±80 PDs, fibroblasts from young to middle-agedcultures accumulate senescent cells more or less expo-
adults may do so after 20±40 PDs, and cells from oldnentially, until they contain only senescent cells. By con-
adults may senesce after 10±20 PDs.trast, S. cerevisiae daughters do not strictly inherit their
These studies suggest that cells in renewable tissuesmother's replicative age, and cultures appear immortal.
may progressively exhaust their replicative life span inS. cerevisiae daughter cells are easily identified and
vivo during aging. If true, tissues and individuals mayseparated from mothers, but this is not true for many
vary considerably in the rate at which replicative poten-other cells. We do not know whether immortal cultures
tial declines because cell turn over varies widely amongfrom other species also contain cells that senesce but
tissues and is very likely influenced by disturbancesdo not transmit their replicative age to daughters.
such as infection, inflammation, or injury.Only two, perhaps three, higher eukaryotic cell types
Species Life Spanmay have an unlimited division potential. Certainly the
Interspecies comparisons suggest that cell replicativegermline is capable of continuous replication (although
life span and organismic life span are genetically related.mature sperm and ova are not). In addition, as noted
Although limited in scope, these studies show that cellsabove, tumor cells are often immortal. Finally, some
from short-lived species tend to senesce after fewerstem cells may be immortal (for example, inner cell mass
PDs than cells from long-lived species (Rohme, 1981;cells, spermatogonia, hematopoietic stem cells), but this
see Stanulis-Praeger, 1987; Campisi et al., 1996). Forhas yet to be critically demonstrated.
example, mouse fibroblasts typically senesce after
10±15 PDs, whereas Galapagos tortoise fibroblasts pro-
What Is Replicative Senescence? liferate for >100 PDs.
Replicative senescence entails an irreversible arrest of These studies suggest that the replicative life span of
cell proliferation and altered cell function. It is controlled cells and chronological life span of organisms may be
by multiple dominant-acting genes and depends on the controlled by overlapping or interacting genes.
number of cell divisions, not time. It also depends on Premature Aging Syndromes
the cell type and on the species and age of the donor A genetic link between aging and replicative life span
(see Stanulis-Praeger, 1987; Cristofalo and Pignolo, is also supported by studies of hereditary premature
1993; Campisi et al., 1996). aging syndromes in man (Martin et al., 1970; see Sta-
Cells acquire three characteristics upon senescence. nulis-Praeger, 1987). The best studied of these is the
Werner syndrome (WS), caused by a recessive mutationFirst, they stably arrest growth with a G1 DNA content,
on chromosome 8p11-p12 (Oshima et al., 1994). WSirreversibly losing the ability to enter Sphase in response
patients are fairly asymptomatic early in life. Thereafter,to physiologic mitogens. The cells remain metabolically
they prematurely develop many, but not all, phenotypicactive, and many genes remain mitogen inducible, but
correlates of age. These include hair and dermal thin-there are changes in a few key growth regulators. These
ning, atherosclerosis, osteoporosis, and cancer. WS isinclude the repression of three positive-acting transcrip-
a segmental progeroid syndrome because only sometional regulators and overexpression of a cyclin-depen-
aging phenotypes are premature. WS cells senesce welldent protein kinase inhibitor (see Campisi et al., 1996).
ahead of age-matched controls. Senescence may alsoSecond, senescent cells acquire altered functions. In
be segmental in WS cells. Senescent WS fibroblasts arefact, by the criteria of a stable irreversible growth arrest
similar to normal counterparts in many ways. However,and change in function, senescent cells resemble termi-
c-fos repression, a hallmark of normal senescence, doesnally differentiated cells (Goldstein, 1990; Campisi et
not occur (Oshima et al., 1995). Thus, a single locusal., 1996). Third, senescent cells acquire resistance to
mutation accelerates age-related processes in vivo andapoptotic (programmed) cell death (Wang, 1995) and
cellular senescence in culture. The WS gene is not yetthus are quite stable. The perception that cellular senes-
cloned but, once identified, may yield extraordinary in-cence leads to cell death is incorrect. It may stem from
sights into cell senescence, aging, and many age-the early finding that senescent cells can be lost when
related diseases.subcultured (Hayflick, 1965; cf. Linskens et al., 1995) or
Physiologic and Molecular Correlatesfrom confusion over the distinction between replicative
Cell senescence and organismic aging also share physi-mortality and cell viability.
ologic and molecular features. For example, senescent
cells and aged tissues are more sensitive to a variety
The Aging Connection of stresses. At a molecular level, the stress inducibility
What is the evidence that cells senesce in vivo, and how of heat shock protein 70 is markedly attenuated in se-
might this cause or contribute to organismic aging? nescent human fibroblasts (Choi et al., 1990) and several
Donor Age tissues from aged rodents (Heydari et al., 1993; Fawcett
Cells cultured from old donors tend to senesce after et al., 1994). In both cases, the attenuation is due to
fewer population doublings (PDs) than cells from young reduced binding of a heat shock transcription factor.
donors. There is considerable scatter in the data, partic- Similar culture/in vivo parallels exist for the regulation
ularly in humans, which may in part be due to genetic of c-fos, certain protease inhibitors, and collagenase
(see Cristofalo and Pignolo, 1993; Campisi et al., 1996).or life history differences (or both). Nonetheless, several
Minireview
499
Another feature shared by senescence in culture and may have a substantial impact in aged tissue. For exam-
ple (see Campisi et al., 1996), senescent human skinaging in vivo is telomere shortening. Telomere shorten-
ing is perhaps the best candidate for a cell division fibroblasts overexpress collagenase and underexpress
collagenase inhibitors. This maywell causeor contributeªcountingº mechanism in normal somatic cells of higher
organisms (see Harley and Villeponteau, 1995; Wright to the collagen breakdown and thin dermis typical of
aged skin. Senescent fibroblasts also underexpress in-and Shay, 1995). In such cells, telomerase is absent or
present at low levels, and telomere length shortens with terleukin-6 and overexpress interleukin-1, cytokines
with pleiotropic inflammatory and immune effects. Thus,PDs in culture and organismic age. In human fibroblasts,
for example, mean telomere length decreases about 50 senescence-linked changes in differentiation could, at
least in principle, have rather profound and far-rangingbp per doubling in culture and 15 bp per year of donor
age (Allsopp et al., 1992). By contrast, telomerase is consequences for tissue function. Moreover, relatively
few senescent cells would be needed for some of theserelatively abundant in replicating germ cells, tumor cells,
and lower eukaryotes, where telomere length is stable. effects.
Finally, resistance to apoptotic death may explain whyFinally, a neutral b-galactosidase activity is expressed
by several types of human cells upon senescence in senescent cells are not cleared and thus accumulate
with age. Indeed, it was recently proposed that caloricculture and increases with age in human skin cells (Dimri
et al., 1995). Because this activity is not associated with restriction, which delays many age-related changes,
may do so by increasing the incidence of apoptosisquiescence, terminal differentiation, or immortality, it
has provided in situ evidence that senescent cells do (Warner et al., 1995).
Thus, age-related decrements in tissue function may,in fact accumulate in aged tissue in vivo.
Postmitotic Cells at least in part, derive from an accumulation of senes-
cent cellsÐwhich cannot proliferate, which resist apop-Organismic aging entails changes in both proliferative
and postmitotic (for example, fat, nerve, and muscle) totic death, and which have an altered phenotype.
Evolutionary theories of aging have suggested thatcells. Age-related changes in postmitotic cells cannot,
of course, be due to replicative senescence. Thus, re- traits selected to optimize health during the period of
reproductive fitness can have unselected deleteriousnewable and postmitotic tissues may age by different
(albeit interacting) mechanisms. If so, model organisms effects later in life. Replicative senescence may have
been selected, at least in mammals, to help ensure thesuch as Drosophila melanogaster or Caenorhabditis
elegans, in which adults are composed entirely of post- relative freedom from cancer that characterizes early
adulthood. However, this trait may be deleterious late inmitotic cells, may provide insights into the aging of post-
mitotic tissue, but not the aging of renewable tissues. life because dysfunctional senescent cells accumulate.
Moreover, because cancer incidence rises with age, itGenes that extend the life span of the postmitotic organ-
ism C. elegans have been identified and are discussed also appears that cellular senescence is an imperfect
tumor suppressive mechanism that fails increasinglyin by Kenyon (1996 [this issue of Cell]). We do not yet
know whether these genes also extend the replicative with age. In fact, it would seem that late in life replicative
senescence wreaks havocÐwhether it succeeds orlife span in C. elegans embryonic cells, nor whether they
or their homologs alter the rate of aging in mammals. fails.
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